RemeGen Co., Ltd. Announces H Shares Register Closure

TipRanksDec 19 19:08

Express News | The USA Biological Security Act was not included in the CR bill.

BreakingsDec 18 15:53

2024 SABCS|Results Unveiled for the Phase III Study of Disitamab Vedotin in Treating HER2-Positive Advanced Breast Cancer With Liver Metastasis

PR NewswireDec 13 07:20

Express News | Shanghai aims to nurture around 10 internationally competitive listed companies in key industries such as integrated circuits, biomedical, and new materials by 2027, forming a merger and acquisition trade scale of 300 billion yuan.

BreakingsDec 10 15:15

The U.S. bioterrorism law has undergone significant changes, the CRO concept has launched a major counterattack, and WuXi AppTec is excited!

Industry pessimistic expectations may improve.

Gelonghui FinanceDec 9 12:10

How to break through the challenges in the development of innovative drugs? The industry suggests focusing on internationalization.

① The year 2024 will be the inaugural year of large-scale authorized trade, and going abroad has become an important direction for the development of local pharmaceutical companies; ② Chinese企业品牌, clinical trial capabilities, data presentation formats, and levels of international operation still need time and practical verification.

cls.cnDec 8 16:48